Among the CTS substrates, p62 levels remained unchanged in cardiac hypertrophy (Fig 2D), whereas cardiac ATPSC and ASNC were moderately downregulated in SCH (Fig 2E and 2F, p = 0.048 and p = 0.039, respectively). Here, TTR is linked to cardiac hypertrophy.